Ventripoint Diagnostics Ltd. (TSXV:VPT)
0.1300
-0.0150 (-10.34%)
May 8, 2026, 3:59 PM EST
Ventripoint Diagnostics Revenue
In the year 2025, Ventripoint Diagnostics had annual revenue of 179.93K CAD with 89.06% growth. Ventripoint Diagnostics had revenue of 104.30K in the quarter ending December 31, 2025, with 61.69% growth.
Revenue (ttm)
279.93K
Revenue Growth
+194.13%
P/S Ratio
135.59
Revenue / Employee
n/a
Employees
n/a
Market Cap
24.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 179.93K | 84.76K | 89.06% |
| Dec 31, 2024 | 95.17K | 45.99K | 93.51% |
| Dec 31, 2023 | 49.18K | -18.98K | -27.85% |
| Dec 31, 2022 | 68.17K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 36.02K | -45.01K | -55.55% |
| Dec 31, 2019 | 81.02K | 20.85K | 34.64% |
| Dec 31, 2018 | 60.18K | 21.27K | 54.68% |
| Dec 31, 2017 | 38.91K | -170.57K | -81.43% |
| Dec 31, 2016 | 209.48K | 158.18K | 308.38% |
| Dec 31, 2015 | 51.30K | -77.16K | -60.07% |
| Dec 31, 2014 | 128.45K | 57.51K | 81.05% |
| Dec 31, 2013 | 70.95K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurora Spine | 25.18M |
| Perimeter Medical Imaging AI | 3.16M |
| Cheelcare | 1.63M |
| Frequency Exchange | 886.47K |
| Theralase Technologies | 816.47K |
| Conavi Medical | 706.00K |
| MedX Health | 473.27K |
| NuGen Medical Devices | 257.95K |
Ventripoint Diagnostics News
- 6 days ago - Ventripoint to Exhibit at the 59th Annual Meeting of the Association for European Paediatric and Congenital Cardiology - TheNewswire
- 12 days ago - Ventripoint's VMS+ (TM) 4.0 Submitted for Regulatory Approval in China by Lishman Global Inc. - TheNewswire
- 17 days ago - Ventripoint Issue Shares for Payment of Debenture Interest - TheNewswire
- 20 days ago - Ventripoint's VMS+(TM) 4.0 Recognized with Gold Edison Award, Validating Leadership and Future Potential - TheNewswire
- 5 weeks ago - Ventripoint Diagnostics Announces Collaboration with the Health Division of the Montecristo Group - TheNewswire
- 7 weeks ago - Ventripoint Partners with First Light Health to Bring AI-Powered Cardiac Diagnostics to Indigenous and Remote Communities - TheNewswire
- 2 months ago - Ventripoint Issues Shares for Payment of Debenture Interest and Reports on Debenture Conversions - TheNewswire
- 2 months ago - Ventripoint Diagnostics Ltd. Signs Commercial Agreement with LG Consulting Solutions to Support VMS+ Deployment in Northern California - TheNewswire